TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group.

Rajen Mody et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.